Publicaciones en colaboración con investigadores/as de Universidad de Alcalá (16)

2024

  1. Age-Related Differences in the Presentation, Management, and Clinical Outcomes of 100,000 Patients With Venous Thromboembolism in the RIETE Registry

    Archivos de Bronconeumologia, Vol. 60, Núm. 3, pp. 143-152

  2. Rate of recurrence after discontinuing anticoagulation in patients with venous thromboembolism within 30 days after COVID-19 vaccine

    European Journal of Clinical Investigation

  3. Risk of recurrence after discontinuing anticoagulation in patients with COVID-19- associated venous thromboembolism: a prospective multicentre cohort study

    eClinicalMedicine, Vol. 73

2022

  1. Impact of neoadjuvant therapy on postoperative complications in non-small-cell lung cancer patients subjected to anatomic lung resection

    European Journal of Surgical Oncology, Vol. 48, Núm. 9, pp. 1947-1953

2021

  1. Comparative clinical prognosis of massive and non-massive pulmonary embolism: A registry-based cohort study

    Journal of Thrombosis and Haemostasis, Vol. 19, Núm. 2, pp. 408-416

2020

  1. Derivation and validation of a clinical prediction rule for thrombolysis-associated major bleeding in patients with acute pulmonary embolism: The BACS score

    European Respiratory Journal, Vol. 56, Núm. 6

  2. Real-Time Dissemination of Aggregate Data on Presentation and Outcomes of Patients With Venous Thromboembolism: The RIETE Infographics Project

    Clinical and Applied Thrombosis/Hemostasis, Vol. 26

2018

  1. A survey of perceptions, attitudes, knowledge and practices of medical oncologists about cancer pain management in Spain

    Clinical and Translational Oncology, Vol. 20, Núm. 8, pp. 1061-1071

2017

  1. Treatment of Right Heart Thrombi Associated with Acute Pulmonary Embolism

    American Journal of Medicine, Vol. 130, Núm. 5, pp. 588-595

2015

  1. Impact of a new definition of Acute kidney injury based on creatinine kinetics in cardiac surgery patients: A comparison with the RIFLE classification

    Interactive Cardiovascular and Thoracic Surgery, Vol. 20, Núm. 3, pp. 338-344

  2. Rivaroxaban in the treatment of venous thromboembolism and the prevention of recurrences: A practical approach

    Clinical and Applied Thrombosis/Hemostasis, Vol. 21, Núm. 4, pp. 297-308

2014

  1. Análisis de impacto presupuestario del uso de fentanilo intranasal en pectina para el tratamiento del dolor irruptivo oncológico

    Pharmacoeconomics - Spanish Research Articles, Vol. 11, Núm. 2, pp. 51-60

2013

  1. Optimal management of breakthrough cancer pain (BCP)

    Clinical and Translational Oncology, Vol. 15, Núm. 7, pp. 526-534

  2. Relationship between the pharmacokinetic properties and efficacy of fentanyl pectin nasal spray in breakthrough cancer pain

    Atencion Farmaceutica, Vol. 15, Núm. 1, pp. 40-45

2012

  1. Breakthrough cancer pain - Still a challenge

    Journal of Pain Research, Vol. 5, pp. 559-566

2009

  1. Nuevos anticoagulantes orales: una visión multidisciplinaria

    Medicina Clinica, Vol. 133, Núm. 13, pp. 508-512